Chemoembolization, Therapeutic
"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.
| Descriptor ID |
D016461
|
| MeSH Number(s) |
E02.520.360.150 E02.926.500.150
|
| Concept/Terms |
Chemoembolization, Therapeutic- Chemoembolization, Therapeutic
- Therapeutic Chemoembolization
- Chemoembolizations, Therapeutic
- Therapeutic Chemoembolizations
|
Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".
Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".
This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in this website by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.
-
Adding Sorafenib-eluting Microspheres to TACE: The Next Step in Hepatocellular Carcinoma Treatment. Radiol Imaging Cancer. 2021 01; 3(1):e200132.
-
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal. Drug Deliv. 2020 Nov 26; 27(1):1729-1740.
-
Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations. Radiographics. 2017 May-Jun; 37(3):963-977.
-
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2017 Jan; 32(1):199-207.
-
A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy. J Vasc Interv Radiol. 2017 Feb; 28(2):231-237.e2.
-
Limitation of Virtual Noncontrasted Images in Evaluation of a Liver Lesion Status Post Transarterial Chemoembolization. J Comput Assist Tomogr. 2016 Jul-Aug; 40(4):557-9.
-
Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy. Liver Transpl. 2016 Apr; 22(4):547-51.
-
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of = 3 cm. HPB (Oxford). 2015 Feb; 17(2):140-9.
-
Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma. HPB (Oxford). 2014 Dec; 16(12):1095-101.
-
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function. HPB (Oxford). 2014 Jul; 16(7):648-55.